Evidence map›Paper›PMID 25088150›Full record

ReviewNature reviews. Microbiology2014

Citrobacter rodentium: infection, inflammation and the microbiota.

James W Collins, Kristie M Keeney, Valerie F Crepin, Vijay A K Rathinam, Katherine A Fitzgerald, B Brett Finlay, Gad Frankel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 332 papers.

0numbers the graph read from it
0cells of the map it votes in
332citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

332 citing papers in PubMed, 513 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The divergentMicrobiology (Reading, England) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Foods (Basel, Switzerland) · 2026
    Article

272 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

James W CollinsMedical Research Council (MRC) Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Flowers Building, Imperial College, London SW7 2AZ, UK.
Kristie M KeeneyMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Valerie F CrepinMedical Research Council (MRC) Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Flowers Building, Imperial College, London SW7 2AZ, UK.
Vijay A K RathinamDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
Katherine A FitzgeraldDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
B Brett FinlayMichael Smith Laboratories, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
Gad FrankelMedical Research Council (MRC) Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Flowers Building, Imperial College, London SW7 2AZ, UK.
University of British Columbia · CA

Funding

Role of PISA; a PYHIN Family Member in Intracellular DNA RecognitionR01AI083713 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., LATZ, EICKE · 2009 to 2013
$2.0M
Metabolic adaptation of Citrobacter during pathogenic colonization of the gutF32AI085761 · NIAID · UNIVERSITY OF BRITISH COLUMBIA · PI KEENEY, KRISTIE MILLER · 2010 to 2012
$153k
CIHRMedical Research Council MR/J006874/1NIAID NIH HHS AI083713NIAID NIH HHS AI085761Wellcome Trust
6 · The paper itself

Abstract

Citrobacter rodentium is a mucosal pathogen of mice that shares several pathogenic mechanisms with enteropathogenic Escherichia coli (EPEC) and enterohaemorrhagic E. coli (EHEC), which are two clinically important human gastrointestinal pathogens. Thus, C. rodentium has long been used as a model to understand the molecular basis of EPEC and EHEC infection in vivo. In this Review, we discuss recent studies in which C. rodentium has been used to study mucosal immunology, including the deregulation of intestinal inflammatory responses during bacteria-induced colitis and the role of the intestinal microbiota in mediating resistance to colonization by enteric pathogens. These insights should help to elucidate the roles of mucosal inflammatory responses and the microbiota in the virulence of enteric pathogens.

Indexed as

Host-Pathogen InteractionsMicrobiotaAnimalsCitrobacter rodentiumColitisColonDietEnterobacteriaceae InfectionsEnterohemorrhagic Escherichia coliEnteropathogenic Escherichia coliEpitheliumImmunity, MucosalIntestine, LargeMiceSignal TransductionVirulence

Identifiers

PMID25088150
OpenAlexW2067320696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.